← Back to headlines
Gilead and Lakefront Complete Ouro Medicines Acquisition
Gilead Sciences and Lakefront have successfully finalized the acquisition of Ouro Medicines, a move expected to impact their respective portfolios and market positions.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
